Yong Jun Chung

Title: Innovations of Yong Jun Chung in Neuropharmacology

Introduction

Yong Jun Chung is a notable inventor based in Taejon-si, South Korea. He has made significant contributions to the field of neuropharmacology, particularly through his innovative work on quinolinic sulfide derivatives. His research focuses on developing compounds that can act as NMDA receptor antagonists, which have potential therapeutic applications in treating various neurodegenerative disorders.

Latest Patents

Yong Jun Chung holds 1 patent for his invention titled "Quinolinic sulfide derivatives acting as NMDA receptor antagonists." This patent describes a class of quinolinic sulfide derivatives that serve as potent and specific antagonists at the strychnine-insensitive glycine binding site on the NMDA receptor complex. The pharmacological profile of these compounds is advantageous for minimizing damage to the central nervous system caused by ischemic or hypoxic conditions, such as stroke, hypoglycemia, cerebral ischemia, cardiac arrest, and physical trauma. Additionally, these compounds may be beneficial in preventing chronic neurodegenerative disorders, including epilepsy, Alzheimer's disease, Huntington's disease, and Parkinsonism. Their NMDA receptor antagonist properties also suggest potential uses as anticonvulsants, analgesics, antidepressants, anxiolytics, and antischizophrenic agents.

Career Highlights

Yong Jun Chung is affiliated with the Korea Research Institute of Chemical Technology, where he continues to advance his research in neuropharmacology. His work has garnered attention for its potential impact on treating debilitating neurological conditions.

Collaborations

Yong Jun Chung collaborates with esteemed colleagues, including No Sang Park and Churl Min Seong, who contribute to his research endeavors and enhance the scope of his innovative projects.

Conclusion

Yong Jun Chung's contributions to the field of neuropharmacology through his patented innovations highlight the importance of research in developing effective treatments for neurodegenerative disorders. His work exemplifies the potential of scientific innovation to improve health outcomes for individuals affected by these conditions.